Press Releases
Relmada Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Relmada Therapeutics Secures First European Patent Covering LevoCap ER
Relmada Therapeutics Announces Notice of Allowance for U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression
Relmada Therapeutics' d-Methadone Receives Orphan Drug Designation for Management of Postherpetic Neuralgia
Relmada Therapeutics to Present at the LD Micro Invitational Conference
Relmada Therapeutics to Present at the 5th Annual Marcum MicroCap Conference
Relmada Therapeutics Announces Promotion of Michael D. Becker to Chief Financial Officer
Relmada Therapeutics Announces Results of In Vivo Study Showing d-Methadone has Antidepressant-like Effects
Relmada Therapeutics to Present at the Joseph Gunnar "Pioneers 2016" Conference
Relmada Therapeutics Provides Additional Details Regarding Upcoming R&D Day
